Rigel Pharma (RIGL) Misses Q1 EPS by 1c

Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.58 million versus the consensus estimate of $3.33 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14